Posted by Michael Wonder on 27 Jun 2022
FDA introduces innovative proposal to advance consumer access to non-prescription drugs
27 June 2022 - Proposed rule is intended to increase options for the development of safe and effective non-prescription drugs.
Today, the U.S. Food and Drug Administration issued a proposed rule titled, “Nonprescription Drug Product with an Additional Condition for Nonprescription Use,” which is intended to broaden the range of marketed nonprescription drugs available to consumers, empowering them to self-treat certain common conditions and improving public health.
